Android app Apple app link

SELLAS announces data indicating key predictor of response to SLS009 in solid cancers

By Yahoo! Finance   |   1 year ago
SELLAS announces data indicating key predictor of response to SLS009 in solid cancers

SELLAS Life Sciences Group released positive preclinical data revealing ASXL1 mutation as a key predictor for SLS009 response in solid cancers. These findings validate the potential of ASXL1 mutations as a biomarker for targeted therapy in solid tumors.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.